II. Pathophysiology
- Malignant transformation of trophoblast
- Villus formation absent
- Trophoblast cells invade myometrium and blood vessels
III. Etiology: Origin of neoplasm
- Molar Pregnancy (50%)
- Spontaneous or Elective Abortion (25%)
- Postpartum delivery of viable fetus (20%)
-
Ectopic Pregnancy (5%)
- Represents 5x the risk of intrauterine pregnancy
IV. Labs
V. Radiology
VI. Management
- Surgery (risk of metastases)
- Suction Curettage while Oxytocin administered
- Hysterectomy if >40 years old
-
Chemotherapy
- Methotrexate 15-30 mg IV x5 days every 2weeks
- Actinomycin D 10 ug/kg x5 days every 2weeks
- Combination therapy for metastases
-
Radiation Therapy
- Indicated for Liver or CNS metastases
VII. Monitoring: Serum Quantitative bhCG
- bHCG every 2 weeks for 2 months then
- bHCG every month for 3 months then
- bHCG every 2 months for 6 months then
- bHCG every 6 months
IX. Prognosis
- Low Risk Patients: 100% five year survival
- Under 4 month history suggesting metastatic disease
- Serum HCG <50 mIU/ml
- No signs of Liver or CNS metastases
- High Risk Patients: 50% five year survival
- Over 4 month history of metastatic disease
- Serum HCG >50 mIU/ml
- Liver or CNS metastases
- Tumor development follows term pregnancy
- Chemotherapy failure